Global Statistics

All countries
Updated on June 23, 2022 8:27 pm
All countries
Updated on June 23, 2022 8:27 pm
All countries
Updated on June 23, 2022 8:27 pm

Global Statistics

All countries
Updated on June 23, 2022 8:27 pm
All countries
Updated on June 23, 2022 8:27 pm
All countries
Updated on June 23, 2022 8:27 pm
- Advertisment -

When Will Covid Vaccines Be Fully Approved

Update Your Proof Of Vaccination

Pfizer first vaccine fully approved by US | Coronavirus | 9 News Australia

If your Nova Scotia COVID-19 Proof of Vaccination has an error or missing information, call to report an issue with your proof of vaccination. You can also call to report an issue if you cant get your Nova Scotia COVID-19 Proof of Vaccination online using your Canadian Health Card number and the email address or phone number you used to book your vaccination appointment.

When you call to report an issue with your proof of vaccination, you may need to provide your:

  • name
  • email address or phone number you used to book your appointment
  • Health Card number
  • type, date and location of COVID-19 vaccine you received

After you report an issue, it should take 2 weeks to get a new digital copy of your Nova Scotia COVID-19 Proof of Vaccination. It can take longer if more information is needed.

Approval Could Lead To More Vaccinations

A from the Kaiser Family Foundation found that 31% of unvaccinated people said they would be more likely to get a COVID-19 vaccine once one receives full approval from the FDA.

“While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated,” Woodcock said. “Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”

The FDA’s full approval applies to people 16 and older. Those ages 12 through 15 can still receive the vaccine under the existing emergency use authorization.

Changing Travel Requirements To Address Covid

Effective All Canadians returning from short trips must take a molecular pre-entry test. The test must be taken outside of Canada.

Effective Temporary enhanced requirements ending for travellers who have been in Botswana, Egypt, Eswatini, Lesotho, Malawi, Mozambique, Namibia, Nigeria, South Africa and Zimbabwe.

Avoid non-essential travel outside Canada, regardless of your vaccination status. Omicron travel health notice

Travellers are eligible to enter or return to Canada if they qualify as a fully vaccinated traveller.

You May Like: How Much Does A Covid 19 Test Cost At Cvs

Cdc Recommends Pfizer Booster Shots For Certain People But Moderna And Johnson & Johnson Booster Shots Not Yet Recommended

Today, the CDC announced that Pfizer booster shots are recommended for certain populations.

This recommendation follows a meeting from yesterday by a CDC expert panel. This panel discussed and voted on the potential risks and benefits of a booster shot. Today, CDC Director, Dr. Rochelle Walensky, formally announced the agencys endorsement of the Pfizer COVID-19 vaccine booster shot.

A few groups of people now qualify for a Pfizer booster shot at least 6 months after their second dose. This includes:

  • People 65 or older

  • People between 50 and 64 who have certain medical conditions, such as asthma, kidney disease, or diabetes

  • People living in long-term care facilities

Other people may qualify for a booster shot depending on the situation. If a healthcare provider decides that the benefits of a booster shot outweigh its risks, they can give a booster shot to certain people at least 6 months after their second dose. This group includes:

  • People between 18 and 49 who have certain medical conditions, such as asthma, kidney disease, or diabetes

  • People between 18 and 64 who work in a setting where theyre frequently exposed to COVID-19

This information only applies to the Pfizer vaccine not the Moderna or Johnson & Johnson vaccines. A Pfizer booster shot can help improve protection against COVID-19 for certain people. If you have questions, please reach out to your healthcare provider for additional guidance.

Why Hasnt The Fda Approved The Vaccines


The three COVID-19 vaccines currently approved for use were granted an emergency use authorizations several weeks after their respective manufacturing companies submitted an application. However, applying for a full license takes much longer.

To gain full approval, companies need to fulfill more requirements and provide the FDA a greater amount of data to review.

An EUA application requires about two months of follow-up with at least half of the vaccine recipients included in phase 3 clinical trials. In contrast, an application for full approval needs at least six months of follow-up data.

There is a lot more data evaluated and summarized for the full approval versus the EUA, and this is one of the primary reasons that the process takes longer, Iahn Gonsenhauser, MD, MBA, chief quality and patient safety officer at The Ohio State Wexner Medical Center, tells Verywell. An additional major requirement of FDA approval, not required for EUA, is the rigor of the review of manufacturing practices including facilities and operations inspections. These are huge multinational operations and this also takes time.

To speed things along, the FDA granted priority review for Pfizers application for a full license. They are required to make their decision by January 2022, but the FDA will likely complete their review far before this deadline.

Read Also: How Much Is A Rapid Test At Cvs

How Is It Possible To Develop A Safe Vaccine So Quickly

While COVID-19 vaccines have been developed faster than any other vaccine in history, safety was just as much a focus as in any other vaccine development. Scientists prioritized COVID-19 vaccine development because of the global emergency.

The speed in the development of COVID-19 vaccine has also been made possible because of the availability of new tools and technologies used in vaccine development.

If You Received One Or More Of Your Doses Outside Of Ontario

If you received one or more doses of the COVID-19 covid 19vaccine out of province, contact your local public health unit to register your information and receive proper documentation. They will verify and record your vaccination records in COVaxON. If you do not have an Ontario health card, they can provide you with a unique pass code called a COVID ID.

Once recorded, you will be able to obtain an enhanced vaccine certificate through the provincial portal at COVID-19 vaccination provincial portal or by calling the Provincial Vaccine Contact Centre at . The contact center agent can email you a secure URL so you can access your vaccine certificate.

Proof of vaccination may also include a vaccination receipt from another jurisdiction that shows the holder is fully vaccinated against COVID-19 covid 19.

Read Also: Are You Guaranteed To Get Covid If Exposed

Using Data To Approve Covid

As of August 2021, hundreds of millions of COVID-19 vaccine doses have been given to people in countries all over the world.

People who get the vaccines are encouraged to report any problems, including any severe side effects. A cooperative effort between the U.S. Centers for Disease Control and Prevention and the FDA, the Vaccine Adverse Event Reporting System collects and analyzes reports from people who received a vaccination and who experienced an adverse event, such as a severe side effect, after getting the shot.

As a result, we now have even more evidence that all three of the FDA-authorized COVID-19 vaccines are safe for most people who receive them, and that all three work well to prevent severe coronavirus disease.

Like other fully approved vaccines used to help prevent illnesses, the FDA-authorized COVID-19 vaccines can cause temporary aches, pains and fever in some people, but the risk of serious side effects is extremely low.

What Can Doctors Do Differently Once Vaccines Are Fully Approved

When is full FDA approval for COVID vaccines coming? | The Story KGW

When a product is fully approved by the FDA, patients can be assured that its recommendation is grounded in large amounts of scientific data.

Full approval allows physicians to prescribe a product and means that the FDA has reviewed all the additional safety, manufacturing, and packaging procedures, Chris Beyrer, MD, an epidemiologist at the Johns Hopkins Bloomberg School of Public Health, tells Verywell. Fully approved products come with the FDA package insert listing all contraindications, warnings, and safety information. The package insert really is the key document for providers to discuss a product with patients.

Although healthcare providers can administer vaccines with either an EUA or a full license, they are not used in exactly the same way.

The biggest difference between administering a drug under EUA versus under full FDA approval is that under EUA, the indications for use must be followed exactly, Gonsenhauser says. No off-label use is allowed. This limits who, when, and why vaccines may be elected to be used.

When a vaccine operates under EUA, there are specific conditions for use that healthcare providers must abide by. A fully approved vaccine may be used off-label, or in circumstances that are slightly different from what is outlined in its license. Healthcare providers may prescribe it to their patients as they see fit.

Read Also: Covid Test Cost Cvs

Vaccine Acceptance In India

Over 80% of the population of India have a positive response for getting anti covid shots. India has one of the lowest vaccine hesitancy in the world.There was vaccine hesitancy in the initial months of 2021, especially in rural India and among poor and tribal populations. Constant government and public awareness drastically reduced vaccine hesitancy. Since May 2021, more than half of daily doses administered in India have been from rural parts. Vaccine centers in India have witnessed large number of people willing to get covid vaccine resulting in overcrowding and mismanagement. Many centers across India in months of April & May reported severe shortage of covid vaccines due to large crowds turning up for vaccination. In cities like Mumbai, New Delhi, Bengaluru many people even after waiting for hours did not receive their covid vaccine due to shortage. Since July, vaccine supply has drastically increased thus India is vaccinating at a very fast pace.

One study published on vaccine acceptance shows that 79.5% of people from Delhi, a union territory in Northern India, want to take a COVID-19 vaccine. In another study which was published from West Bengal, a state in Eastern India, has shown that 77.27% of people want to take the COVID-19 vaccine. According to the finding from these two studies, it can be expected that over 75% of people want to get a COVID-19 vaccine.

Do The Covid19 Vaccines Have Adverse Reactions

Like all medicines, vaccines can cause adverse reactions. Most of these are mild and short term, such as pain at the injection site, tiredness or a headache. Most reactions to vaccines are mild and go away within a few days on their own. The typical side effects can be managed with rest and lots of liquids.

Many people don’t get any side effects. Some people might feel slightly unwell because their immune system is responding to the vaccine, but this is not an illness.

More serious or long-lasting side effects to vaccines are possible but extremely rare.

Read Also: How Long Does A Cvs Covid Test Take

Boost Protection With A Third Dose

Vaccine effectiveness against infection may decline over time especially with the highly transmissible Omicron variant but they remain the best way to prevent severe illness and death. Third doses can boost immunity to improve protection and limit spread.

Everyone 18 and older can get a third dose 5 months after their second dose.

Fdas Vaccine Advisory Committee Votes On Pfizer Booster Shots


Today, the FDAs Vaccine and Related Biological Products Advisory Committee met to discuss Pfizers application for COVID-19 vaccine booster shots in people at least 16 years old . The VRBPAC is the FDA committee that reviews the safety and effectiveness of vaccines before theyre fully approved for use in the public.

Sixteen committee members voted against approving the application, and two members voted in favor of approval. This means that the committee recommended against approving the sBLA.

The decision was followed by a second vote to approve an EUA for booster doses in certain high-risk groups. These groups included adults at least 65 years old and people at high risk for severe COVID-19 who are at least 6 months out from their initial vaccine series. All 18 members voted in favor of the EUA, which may also include other groups with high COVID-19 exposure risk, like healthcare workers.

The FDA makes the final call, and they have yet to issue their decision. But if they follow the committees recommendation, it will likely include a booster EUA for specific groups.

A CDC expert panel will meet after the FDAs decision to provide specific recommendations on who should receive a booster shot.

Recommended Reading: Cvs Test Results How Long Covid

What To Do To Keep Yourself And Others Safe From Covid

WHO recommends the following combined actions:

  • Maintain at least a 1-metre distance between yourself and others to reduce your risk of infection when they cough, sneeze or speak maintain an even greater distance between yourself and others when indoors.
  • Always wear a mask in public places and when with others. The appropriate use, storage and cleaning or disposal are essential to make masks as effective as possible.
  • Clean your hands before you put your mask on, as well as before and after you take it off, and after you touch it at any time.
  • Make sure it covers your nose, mouth and chin.
  • When you take off a mask, store it in a clean plastic bag, and every day either wash it if its a fabric mask, or dispose of a medical mask in a trash bin.
  • Get the COVID-19 vaccine.

How can I learn more about COVID-19 vaccines?

Everyone is encouraged to rely on reputable and authoritative sources of information, such as health care providers and public health officials, to help them make informed choices and stay up to date. The latest information about COVID-19 vaccines from the World Health Organization is available.

Covid Vaccines: Emergency Use Authorization Vs Approval

Not every vaccine is granted an emergency use authorization before full approval. The FDA authorized three COVID-19 vaccines to answer an urgent need to protect people from the coronavirus pandemic, which was a public health emergency.

When it was clear in 2020 that COVID-19 was a rapidly spreading, dangerous disease, the FDA worked with vaccine manufacturers, independent laboratories, academic research centers and nonprofit organizations to quickly gather and interpret large amounts of data on the vaccines.

The data showed that the vaccines were very effective in preventing severe COVID-19 and the risks of serious side effects was extremely low. Based on these findings, the FDA granted the EUA so people could be vaccinated earlier in the approval process and be protected from serious effects of COVID-19.

Full approval is granted when, over time, the FDA has amassed even more scientific evidence to support use of the COVID-19 vaccines, showing that the benefits of the vaccine are greater than its risks, and that the vaccines can be manufactured reliably, safely and with consistent quality.

Also Check: Cost Of Cvs Covid Test

Positive Arrival Test Or Symptoms After Your Arrival

Monitor for symptoms for 14 days after your arrival.

If a fully vaccinated traveller or unvaccinated child under 12 years of age tests positive:

  • report your test results and/or symptoms to PHAC by calling 1-833-641-0343

If a parent, step-parent, guardian, or tutor experiences symptoms or tests positive:

You must provide proof of your test results, if asked, to any federal, provincial, territorial or municipal government official or peace officer.

Can I Take A Vaccine If I Am Pregnant

FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine

There is little data available to assess vaccine safety in pregnancy. Pregnant women may receive the vaccine if the benefit of vaccinating a pregnant woman outweighs the potential vaccine risks. Pregnant women should consult their doctor about the vaccine to get information about the risks and benefits to be able to make an informed choice about it.

Also Check: Cvs Testing Cost

Pfizer Submits Authorization Request To Expand Booster Eligibility To All Adults

Yesterday, Pfizer submitted an to the FDA to expand its COVID-19 vaccine booster eligibility to all adults at least 18 years old. Currently, Pfizer booster shots are only authorized for certain groups, including older adults and people at high risk for severe illness.

Pfizer is now requesting broader authorization based on clinical trial results that studied the effects of booster shots. The trial enrolled more than 10,000 participants.

Everyone in this study received two doses of the Pfizer vaccine, but some people also received a booster shot. During the study, more people who didnt get a booster shot developed COVID-19 compared to those who got one.

As of today, theres no FDA vaccine expert panel meetings scheduled to review Pfizers request. But it has been reported that the FDA could make the call without the panel before Thanksgiving.

Moderna Requests Fda Authorization For Half

Like Pfizers vaccine, Modernas COVID-19 vaccine is also for a booster dose in certain immunocompromised people. This week, its been reported that the company has also requested FDA authorization for a half-dose booster for people eligible to get the vaccine. The original Moderna vaccine contains 100 mcg of mRNA, whereas the booster would contain 50 mcg.

Although the VRBPAC meeting on September 17 will be focusing on additional COVID-19 doses including Pfizers booster application the FDA announcement doesnt specify if Modernas booster application will also be reviewed. However, well know more once the meeting agenda is made available to the public no later than 2 business days before the meeting.

Don’t Miss: Cvs Pcr Test Cost

Booking Your 2nd Dose

People aged 16 or over are eligible for a 2nd dose.

People aged 18 or over should have their 2nd dose from 8 weeks after their 1st dose.

Most people aged 16 or 17 should have their 2nd dose from 12 weeks after their 1st dose.

- Advertisment -

Hot Topics

- Advertisment -

Related Articles